The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features.
暂无分享,去创建一个
R. Fisher | T. Grogan | T. Miller | M. Gulley | R. Braziel | M. Slovak | J. Unger | D. Arber | R. Tubbs | C. Leith | C. Kjeldsberg | C. Spier
[1] A. Killeen. Molecular pathology protocols , 2000 .
[2] J Hermans,et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. , 1998, Blood.
[3] D. Weisenburger,et al. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] A. Hildesheim,et al. Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. , 1998, Blood.
[5] M. Slovak,et al. Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] J C Reed,et al. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. , 1997, Blood.
[7] B. Nathwani,et al. A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project , 1997 .
[8] W. Ludwig,et al. Expression of intercellular adhesion molecule 1 (ICAM‐1) in childhood acute lymphoblastic leukaemia: correlation with clinical features and outcome , 1997, British journal of haematology.
[9] T. Liehr,et al. FISH analysis of interphase nuclei extracted from paraffin-embedded tissue. , 1995, Trends in genetics : TIG.
[10] L. Young,et al. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma. , 1995, Blood.
[11] P. Nowell,et al. Detection of myc translocations in lymphoma cells by fluorescence in situ hybridization with yeast artificial chromosomes. , 1995, Blood.
[12] H Stein,et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.
[13] R. Ambinder,et al. Detection and characterization of Epstein-Barr virus in clinical specimens. , 1994, The American journal of pathology.
[14] C. Bloomfield,et al. Prognostic factors for therapeutic outcome of diffuse small non‐cleaved cell lymphoma in adults , 1994, American journal of hematology.
[15] Ellen,et al. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial. , 1994, Blood.
[16] J. Liu,et al. Rearrangement of the BCL‐2 Gene in Follicular Lymphoma: Detection by PCR in Both Fresh and Fixed Tissue Samples , 1993, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[17] T M Grogan,et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.
[18] T. Grogan,et al. Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence. , 1993, Leukemia.
[19] K. Bhatia,et al. The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors. , 1992, Cancer research.
[20] E. Green,et al. Fluorescence in situ hybridization of YAC clones after Alu-PCR amplification. , 1992, Genomics.
[21] D. Longo,et al. Histogenetic correlations between subcategories of small noncleaved cell lymphomas. , 1992, Blood.
[22] T. Crook,et al. p53 is frequently mutated in Burkitt's lymphoma cell lines. , 1991, The EMBO journal.
[23] F. Ferrara,et al. Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders. , 1990, Blood.
[24] C. Meijer,et al. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). , 1990, Leukemia.
[25] F. Rilke,et al. Expression of differentiation and adhesion molecules in sporadic Burkitt's lymphoma , 1990, Hematological oncology.
[26] T. Grogan,et al. Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] D. Weisenburger,et al. Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome. The Nebraska Lymphoma Study Group. , 1990, Blood.
[28] G. Lenoir,et al. Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus. , 1990, Blood.
[29] R. Greil,et al. Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour. , 1989, Clinical and experimental immunology.
[30] J. Shuster,et al. Diffuse small noncleaved cell lymphoma in children, Burkitt's versus non‐Burkitt's types. Results from the pediatric oncology group and st. jude children's research hospital , 1989, Cancer.
[31] M. Oken,et al. bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma. , 1989, The New England journal of medicine.
[32] T. Grogan,et al. HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma. , 1988, The Journal of clinical investigation.
[33] A. Rickinson,et al. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein- Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance , 1988, The Journal of experimental medicine.
[34] R. Sposto,et al. The pathology of non-Hodgkin's lymphoma of childhood: II. Reproducibility and relevance of the histologic classification of "undifferentiated" lymphomas (Burkitt's versus non-Burkitt's). , 1987, Human pathology.
[35] T. Grogan,et al. An ultrastructural morphometric and immunophenotypic evaluation of Burkitt's and Burkitt's-like lymphomas. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[36] R. Warnke,et al. Small noncleaved cell lymphoma: an immunophenotypic study of 18 cases and comparison with large cell lymphoma. , 1986, Human pathology.
[37] I W Taylor,et al. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. , 1983, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[38] R. Warnke,et al. A comparative study of Burkitt's and non‐Burkitt's “undifferentiated” malignant lymphoma: Immunologic, cytochemical, ultrastructural, cytologic, histopathologic, clinical and cell culture features , 1982, Cancer.
[39] T. Maniatis,et al. The nucleotide sequence of the human β-globin gene , 1980, Cell.
[40] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[41] M. Gulley,et al. Molecular Methods for Detecting Epstein-Barr Virus (Part I) : In Situ Hybridization to Epstein-Barr Virus-Encoded RNA (EBER) Transcripts. , 2001, Methods in molecular medicine.
[42] J. Diebold,et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. , 1999, American journal of clinical pathology.
[43] D. Jong,et al. Clinical Relevance of BCL 2 , BCL 6 , and MYC Rearrangements in Diffuse Large B-Cell Lymphoma , 1998 .
[44] S. Poppema,et al. Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] I. Magrath. The pathogenesis of Burkitt's lymphoma. , 1990, Advances in cancer research.
[46] Correlation of Chromosome Abnormalities With Histologic and Immunologic Characteristics in Non-Hodgkin ’ s Lymphoma and Adult , 2022 .
[47] J. Whang‐Peng,et al. Cytogenetic studies in non-African Burkitt lymphoma. , 1980, Blood.